Oxycodone/Naloxone G.L. (Oxycodone Hydrochloride, Naloxone Hydrochloride Dihydrate)

Oxycodone Hydrochloride, the active ingredient in Oxycodone/Naloxone G.L., is an opioid analgesic presented as a combination formulation for oral use. It is used to manage moderate to severe pain in adult patients when other analgesics are insufficient. GNH USA supplies Oxycodone/Naloxone G.L. as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Oxycodone/Naloxone G.L. as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Oxycodone/Naloxone is indicated for pain management within the opioid pathway and is used in the following clinical situations:

- Chronic non‑cancer pain: provides opioid analgesia while reducing opioid‑induced constipation. - Cancer‑related pain: offers strong analgesic effect with a built‑in antagonist to limit constipation. - Post‑operative pain: delivers effective pain relief after surgery with a lower risk of bowel dysfunction. - Pain in patients requiring opioid rotation: facilitates switching from other opioids while managing bowel side effects. - Severe acute pain: supplies rapid, potent analgesia when non‑opioid options are inadequate.

Adverse reactions may range from mild to severe and should be monitored during therapy.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Constipation: reduced bowel motility despite naloxone's protective effect. - Dizziness: transient light‑headedness. - Somnolence: increased sleepiness. - Dry mouth: reduced salivation. - Headache: mild cranial discomfort.

Serious or Rare Side Effects: - Respiratory depression: slowed breathing, potentially life‑threatening. - Severe hypotension: marked drop in blood pressure. - Opioid dependence or abuse: risk of addiction with prolonged use. - Hepatic impairment: elevated liver enzymes. - Allergic reactions: rash, pruritus, or anaphylaxis. - adrenal insufficiency: rare endocrine disturbance.

When prescribing Oxycodone/Naloxone, clinicians should consider several safety measures:

- Assess pain severity: ensure opioid therapy is appropriate for the level of pain. - Review medical history: check for respiratory disorders, head injury, or substance abuse. - Monitor liver function: patients with hepatic impairment may need dose adjustments. - Educate patients: advise on signs of opioid overdose and proper use. - Avoid concurrent CNS depressants: limit use of alcohol, benzodiazepines, or other sedatives. - Store at below 25°C: keep in the original packaging and protect from moisture.

Oxycodone/Naloxone has several drug‑interaction considerations that can affect safety and efficacy.

Major Interactions (Avoid): -  C   ​           ​  ​            ​  ​              ​   ​           ​          ​      ​ 

Moderate Interaction ( Monitor Closely): -  C  ");